CA
ZOM

Cetera Advisors’s Zomedica Corp. ZOM Stock Holding History

Cetera Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$2.63K Buy
+18,052
New +$2.52K ﹤0.01% 2421

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Cetera Advisors's ZOM Position: Q1 2024 in Review

Cetera Advisors opened a new position in Zomedica Corp. (ZOM) in Q1 2024: 18,052 shares worth $2.63K. The stake represents ﹤0.01% of the portfolio and ranks #2421 among its holdings.

99 funds tracked by Wall St. Rank hold ZOM as of Q1 2024.

  • Cetera Advisors held 18,052 shares of Zomedica Corp. worth $2.63K as of Q1 2024.
  • Zomedica Corp. was a new Cetera Advisors position in Q1 2024.
  • Zomedica Corp. made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2421 holding.
  • 99 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.